| 前收市價 | 27.49 |
| 開市 | 0.00 |
| 買盤 | 0.00 x 0 |
| 賣出價 | 0.00 x 0 |
| 今日波幅 | 0.00 - 0.00 |
| 52 週波幅 | |
| 成交量 | |
| 平均成交量 | 1,633,252 |
| 市值 | 1.117B |
| Beta 值 (5 年，每月) | 1.54 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.45 |
| 業績公佈日 | 2024年11月06日 - 2024年11月11日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 20.75 |
Insider MonkeyAcquisition News Lifted Silk Road Medical (SILK) in Q2
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter the fund returned -1.59% (gross) and -1.83% (net), compared to a -2.92% return for the Russell 2000 Growth Index. The equity markets performed well […]
- Insider Monkey
Silk Road Medical (SILK) Surged After the Acquisition News
Wasatch Global Investors, an asset management company, released its “Wasatch Micro-Cap Growth-U.S. Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here. Micro-cap stocks saw a decline in the second quarter of this year following a robust start to the year due to a difficult macro environment and a narrowly focused […]
Insider MonkeyHere’s Why Silk Road Medical (SILK) was up 47.8% in Q2
Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund (Institutional Shares) declined 7.78% underperforming the 2.92% return for the Russell 2000 Growth Index. The lion’s share of negative attribution and 6.52% of negative performance […]
